|
Bailen R, Pascual-Cascon MJ, Guerreiro M, Lopez-Corral L, Chinea A, Bermudez A, Sampol A, Heras I, Garcia-Torres E, Torres M, Roca JR, Herruzo B, Sanz J, Fonseca M, Herrera P, Colorado M, Bento L, Lopez-Godino O, Martin-Calvo C, Fernandez-Caldas P, Marcos-Jubilar M, Sanchez-Ortega I, Solano C, Noriega V, Humala K, Oarbeascoa G, Diez-Martin JL, Kwon M; Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular (GETH). Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC. Transplant Cell Ther. 2022 Apr;28(4):204.e1-204.e10. doi: 10.1016/j.jtct.2022.01.020. Epub 2022 Jan 31. PubMed PMID: 35108627.
AÑO: 2022; IF: 3.2
|
35108627
|
Gutierrez A, Bento L, Novelli S, Martin A, Gutierrez G, Queralt Salas M, Bastos-Oreiro M, Perez A, Hernani R, Cruz Viguria M, Lopez-Godino O, Montoro J, Pinana JL, Ferra C, Parody R, Martin C, Espanol I, Yanez L, Rodriguez G, Zanabili J, Herrera P, Varela MR, Sampol A, Solano C, Caballero D, On Behalf Of The Grupo Espanol de Trasplante de Progenitores Hematopoyeticos Geth And Grupo Espanol de Linfoma Y Trasplante Autologo Geltamo. Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience. Cancers (Basel). 2022 May 27;14(11):2673. doi: 10.3390/cancers14112673. PubMed PMID: 35681653; PubMed Central PMCID: PMC9179246.
AÑO: 2022; IF: 6.575
|
|
Bailen R, Alenda R, Herruzo-Delgado B, Acosta-Fleitas C, Valles A, Esquirol A, Fonseca M, Solan L, Sanchez-Vadillo I, Bautista G, Bento L, Lopez-Godino O, Perez-Martinez A, Torrent A, Zanabili J, Calbacho M, Moreno MA, Pascual-Cascon MJ, Guerra-Dominguez L, Chinea A, Garcia-Cadenas I, Lopez-Corral L, Boix-Giner F, Lopez Lorenzo JL, Humala K, Duarte R, Sampol A, Heras I, Vicario JL, Balas A, Oarbeascoa G, Fernandez-Caldas P, Anguita J, Kwon M. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Front Immunol. 2023 May 26;14:1165759. doi: 10.3389/fimmu.2023.1165759. eCollection 2023. PubMed PMID: 37304258; PubMed Central PMCID: PMC10250708.
AÑO: 2023; IF: 5.7
|
|
Fonseca-Santos M, Bailen R, Lopez-Godino O, Herruzo-Delgado B, Bermudez MA, Garcia-Cadenas I, Huguet-Mas M, Ferra-Coll C, Esquirol A, Cortes-Rodriguez M, Yanez-Sansegundo L, Pascual-Cascon MJ, Heras I, Kwon M, Lopez-Corral L; Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular. Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC. Transplantation. 2024 Oct 1;108(10):2134-2143. doi: 10.1097/TP.0000000000005034. Epub 2024 Sep 24. PubMed PMID: 38685204.
AÑO: 2024; IF: 5.0
|
|
Mora E, Montoro J, Balaguer A, Rovira M, Cabrero M, Heras I, Ribera JM, Antelo G, Martin AA, Lopez Godino O, Torrent A, Villalba M, Chorao P, Sanz MA, Sanz J; Grupo Espanol de Trasplante Hematopoyetico (GETH). Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia. Bone Marrow Transplant. 2024 Aug;59(8):1137-1145. doi: 10.1038/s41409-024-02298-z. Epub 2024 May 16. PubMed PMID: 38755458.
AÑO: 2024; IF: 5.2
|